Samarbejdsaftaler i biotek

Union Jack
Dannebrog

Samarbejdsaftaler i biotek

Show simple item record

dc.contributor.author Dahl, Jesper Hornstrup
dc.date.accessioned 2010-01-13
dc.date.accessioned 2010-01-14T10:50:33Z
dc.date.available 2010-01-14T10:50:33Z
dc.date.issued 2010-01-14T10:50:33Z
dc.identifier.uri http://hdl.handle.net/10417/828
dc.description.abstract The purpose of this master thesis is to provide an answer the question as to why the biotech business as a whole is incapable of being profitable. Research has shown, that in the lifetime of the biotech business (since the founding of Genentech in 1976), the business has not been able to create a profit. A hypothesis is created which explains the inefficient contracts as an expression of the parties willingness to protect their prior knowledge. The transaction economic bilateral hostage model by Williamson is used to analyze the collaboration agreement as a contract comprised reciprocal investments in specialized assets, in the form of knowledge. Subsequently, a legal analysis of the possibility to renegotiate the collaboration agreement due to changed circumstances. Finally a solution to the problem is presented, that focuses on optimizing the market for knowhow, by creating a contracting model comprised of a mix of governance structures that addresses the different relationship between the contracting parties over time. In the first period after the formation of the contract, the interaction between the parties is based on market norms and should therefore be based on a governance structure comprised of contractual governance. At the same time, a governance structure based on relational governance will be introduced in order to facilitate the emergence of social norms between the parties. Over time, trust and loyalty will develop around relational governance model, making the contractual governance model obsolete. This governance mix will facilitate a high degree of knowledge sharing and joint solution of problems emerging during the collaboration. As a result of this, the collaboration agreements will function more efficiently and become drivers for renewed growth in the business. en_US
dc.format.extent 78 s. en_US
dc.language dan en_US
dc.subject.other Kandidatafhandlinger en_US
dc.title Samarbejdsaftaler i biotek en_US
dc.type mop en_US
dc.accessionstatus modt10jan13 jobrmo en_US
dc.contributor.corporation Copenhagen Business School. CBS en_US
dc.contributor.corporationshort Law Department. LAW en_US
dc.contributor.corporationshort Juridisk Institut. JUR en_US
dc.contributor.department MSc in Business Administration and Commercial Law en_US
dc.contributor.departmentshort 32 en_US
dc.description.notes Cand.merc.(jur.). Erhvervsøkonomi og erhvervsjura en_US
dc.idnumber x656604742 en_US
dc.publisher.year 2009 en_US
dc.publisher.city Frederiksberg en_US
dc.title.subtitle Hvordan kan samarbejdsaftaler indenfor bioteknologi konciperes, så de kan skabe mere værdi for virksomhederne? en_US

Files Size Format View
jesper_hornstrup_dahl.pdf 615.0Kb PDF View/Open

The following license files are associated with this item:

This item appears in the following Collection(s)

Show simple item record